Skip to main content
RAPS 2024 Global Regulatory Strategy Conference Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Rob Berlin, JD/MPH

Head US Regulatory Policy
GSK
Columbia, Maryland, United States

Rob Berlin is the Head of U.S. Regulatory Policy at GlaxoSmithKline (GSK). Rob leads a team focused on driving U.S. regulatory policy, advocacy, and intelligence activities, to ensure optimal advancement and lifecycle management of GSK’s product portfolio. Rob came to GSK from the FDA where he most recently served as the Director of the Division of Clinical Policy within the Office of New Drug (OND) Policy, an office he helped to establish as a founding member of the leadership team. Prior to joining OND Policy, Rob worked in CDRH, FDA’s Office of Policy, and in the Office of Chief Counsel. He began his career at Hogan & Hartson (now Hogan Lovells) after completing his law degree and M.P.H. in Epidemiology at the University of Minnesota.

Disclosure information not submitted.

Presentation(s):